Second-line therapy for severe pediatric ulcerative colitis

被引：0
|
作者：
Susan R. Orenstein
机构：
来源：
Current Gastroenterology Reports | 2009年 / 11卷 / 3期
关键词：
Ulcerative Colitis; Ulcerative Colitis Patient; Toxic Megacolon; Intravenous Steroid; Steroid Dependency;
D O I：
10.1007/s11894-009-0026-2
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：167 / 169
页数：2
相关论文
共 50 条
  • [1] Severe paediatric ulcerative colitis: incidence, outcomes and optimal timing for second-line therapy
    Turner, D.
    Walsh, C. M.
    Benchimol, E. I.
    Mann, E. H.
    Thomas, K. E.
    Chow, C.
    McLernon, R. A.
    Walters, T. D.
    Swales, J.
    Steinhart, A. H.
    Griffiths, A. M.
    GUT, 2008, 57 (03) : 331 - 338
  • [2] Adalimumab as a second-line biological therapy in children with refractory ulcerative colitis
    Volonaki, Eleni
    Mutalib, Mohamed
    Kiparissi, Fevronia
    Shah, Neil
    Lindley, Keith J.
    Elawad, Mamoun
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 27 (12) : 1425 - 1428
  • [3] Tofacitinib in Ulcerative Colitis - Second-Line Therapy, First-Rate Results
    Harindranath, Sidharth
    DIGESTIVE DISEASES AND SCIENCES, 2024, : 3116 - 3118
  • [4] Effectiveness and safety of a second-line rescue therapy for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study)
    Garcia, M. J.
    Riestra, S.
    Amiot, A.
    Julsgaard, M.
    de la Filia, I. Garcia
    Calafat, M.
    Aguas, M.
    de la Pena, L.
    Roig-Ramos, C.
    Caballol, B.
    Casanova, M. J.
    Farkas, K.
    Boysen, T.
    Bujanda, L.
    Cuaran, C.
    Dobru, D.
    Fousekis, F.
    Gargallo-Puyuelo, C. J.
    Savarino, E.
    Calvet, X.
    Huguet, J. M.
    Kupcinskas, L.
    Lopez-Cardona, J.
    Raine, T.
    Van Oostrom, J.
    Gisbert, J. P.
    Chaparro, M.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 911 - 912
  • [5] Ustekinumab Versus Tofacitinib as Second-Line Therapy for Ulcerative Colitis: A Retrospective, Observational Study
    Galatowitsch, John
    Haydek, John P.
    Ahmed, Waseem
    Fennimore, Blair
    Cheng, Debbie
    Steiner, Calen A.
    Click, Benjamin
    Gerich, Mark E.
    Oonk, Alexis
    Scott, Frank I.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S649 - S651
  • [6] Budesonide as second-line therapy for microscopic colitis
    Randall, Charles
    Taboada, Carlo
    Gossen, Gary
    Havranek, Russell
    Fincke, Christopher
    Adame, Rodrigo
    Villarreal, Alejandro
    Rendon, Luis
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S426 - S426
  • [7] Fecal Osteoprotegerin May Guide the Introduction of Second-line Therapy in Hospitalized Children with Ulcerative Colitis
    Sylvester, Francisco A.
    Turner, Dan
    Draghi, Andrew, II
    Uuosoe, Krista
    McLernon, Robin
    Koproske, Kristen
    Mack, David R.
    Crandall, Wallace V.
    Hyams, Jeffrey S.
    LeLeiko, Neal S.
    Griffiths, Anne M.
    INFLAMMATORY BOWEL DISEASES, 2011, 17 (08) : 1726 - 1730
  • [8] Inmunomodulation in ulcerative colitis.: Second line therapy?
    Ibanez, Patricio
    Glasinovic, E.
    Gatica, M.
    Vial, Paula
    Valdivieso, Eduardo
    Saenz, Roque
    GASTROINTESTINAL ENDOSCOPY, 2007, 65 (05) : AB259 - AB259
  • [9] METHOTREXATE THERAPY FOR ULCERATIVE COLITIS IN THE DISTRICT GENERAL HOSPITAL SETTING: A USEFUL SECOND-LINE OPTION FOR PATIENTS
    Hammond, C.
    Disney, B. R.
    Xiarchou, A.
    Chohan, D.
    Coyle, J.
    Wood, G.
    Raman, S.
    Sung, E.
    GUT, 2014, 63 : A69 - A70
  • [10] Comparative efficacy of vedolizumab and adalimumab as second-line therapy in ulcerative colitis patients previously treated with infliximab
    Favale, A.
    Onali, S.
    Caprioli, F.
    Pugliese, D.
    Armuzzi, A.
    Macaluso, F. S.
    Orlando, A.
    Viola, A.
    Fries, W.
    Mocci, G.
    Chicco, F.
    Usai, P.
    Rispo, A.
    Castiglione, F.
    Calabrese, E.
    Biancone, L.
    Monteleone, G.
    Fantini, M. C.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S465 - S465
12345